Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
180 Life Sciences Corp. - Common Stock
(NQ:
ATNF
)
1.150
-0.030 (-2.54%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about 180 Life Sciences Corp. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 08, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 06, 2022
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 06, 2022
Good morning, trader! We're starting off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!
Via
InvestorPlace
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Releases Status Update on MHRA Interaction
December 01, 2022
Via
Investor Brand Network
Stocks That Hit 52-Week Lows On Thursday
October 20, 2022
Thursday saw 177 companies set new 52-week lows.
Via
Benzinga
180 Life Sciences Provides Update on Progress To Seek Medicines and Healthcare Products Regulatory Agency Marketing Authorization for Anti-TNF Treatment of Early Stage Dupuytren’s Contracture
November 30, 2022
From
180 Life Sciences Corp.
Via
GlobeNewswire
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Participation in Upcoming Biotech Conference
November 21, 2022
Via
Investor Brand Network
180 Life Sciences to Participate in A.G.P.’s Virtual Biotech Conference to be Held November 30 – December 1, 2022
November 21, 2022
From
180 Life Sciences Corp.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
October 19, 2022
On Wednesday, 200 companies hit new 52-week lows.
Via
Benzinga
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Adalimumab Has Promise as Treatment for Early-Stage Dupuytren’s Disease
November 15, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
CORRECTION: Adalimumab Found To Be A Likely Cost-Effective Treatment for Early-Stage Dupuytren’s Disease
November 15, 2022
From
180 Life Sciences Corp.
Via
GlobeNewswire
Adalimumab Found To Be A Likely Cost-Effective Treatment for Early-Stage Dupuytren’s Disease
November 15, 2022
From
180 Life Sciences Corp.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 09, 2022
Gainers Merrimack Pharmaceuticals (NASDAQ:MACK) shares rose 180.0% to $11.2 during Wednesday's pre-market session. The company's market cap stands at $150.1 million. As per the news, the Q3 earnings...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 26, 2022
It's time to start off the day with a breakdown of the biggest pre-market stock movers for Wednesday morning and the latest news!
Via
InvestorPlace
Why IBM Shares Are Trading Higher; Here Are 21 Stocks Moving Premarket
October 20, 2022
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) rose 20.9% to $0.1063 in pre-market trading after dipping 26% on Wednesday. COMSovereign recently announced receipt of Nasdaq listing determination.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
October 28, 2022
During Friday, 125 stocks hit new 52-week lows.
Via
Benzinga
Ron Bauer, Author of Exit Plan: How to Raise Money & Go Public, has a book release planned for December 2022
September 29, 2022
Via
Get News
BioMedNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Issues Letter to Stockholders
September 26, 2022
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 26, 2022
Gainers Ontrak (NASDAQ:OTRKP) shares increased by 28.8% to $2.1 during Monday's pre-market session.
Via
Benzinga
Why Kaspien Holdings Is Trading Lower By 13%; Here Are 21 Stocks Moving Premarket
September 14, 2022
Gainers Aditxt, Inc. (NASDAQ: ADTX) rose 54.3% to $28.56 in pre-market trading following effect of 1:50 reverse stock split.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 12, 2022
Gainers OpGen (NASDAQ:OPGN) shares rose 20.6% to $0.52 during Monday's after-market session. This security traded at a volume of 927.4K shares come close, making up 324.6% of its average volume over...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 24, 2022
Via
Benzinga
Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session
August 22, 2022
Losers
Via
Benzinga
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
August 23, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of...
Via
Benzinga
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Enrolls First Patient in Early-Stage Frozen Shoulder Trial
August 22, 2022
Via
Investor Brand Network
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket
August 22, 2022
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public...
Via
Benzinga
180 Life Sciences: Why Investors Should Take Notice
August 15, 2022
180 Life Sciences is an under the radar stock worthy of a closer look. We sat down with CEO Dr. James Woody to dig deeper into ATNF to learn if the stock merits being added to your portfolio.
Via
Talk Markets
Why Is Turquoise Hill Resources Down By 18%: Here Are 31 Stocks Moving Premarket
August 15, 2022
Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 31.2% to $0.6931 in pre-market trading as the company presented positive data from ongoing ReSPECT™ clinical trials at the Annual Conference...
Via
Benzinga
InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Grant Award to the University of Oxford to Conduct Anti-TNF Therapy Trial
July 27, 2022
Via
Investor Brand Network
180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program
July 27, 2022
From
180 Life Sciences Corp.
Via
GlobeNewswire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.